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A New Disorder in UV-Induced Skin Cancer with
Defective DNA Repair Distinct from Xeroderma
Pigmentosum or Cockayne Syndrome
Satoru Hashimoto1, Kiyofumi Egawa2, Hironobu Ihn2, Ai Igarashi3, Tsukasa Matsunaga3, Satoshi Tateishi1
and Masaru Yamaizumi1,{
We report the characterization of a Japanese woman who exhibited many freckles and skin cancers in sun-
exposed areas, but displayed no photosensitivity. Fibroblasts (KPSX7) derived from this patient showed similar
UV sensitivity to that of normal human fibroblasts. The KPSX7 cells showed normal levels of unscheduled DNA
synthesis, recovery of RNA synthesis, recovery of replicative DNA synthesis, protein-binding ability to UV-
damaged DNA, and post-translational modification of xeroderma pigmentosum (XP) C. These results indicate
that the patient had neither XP nor Cockayne syndrome. Although these results suggest that the KPSX7 cells
were proficient in nucleotide excision repair activity, host-cell reactivation (HCR) activity of KPSX7 cells was
reduced. Furthermore, introduction of UV damage endonuclease into the cells restored repair activity in the
HCR assay to almost normal levels. These results indicate that KPSX7 cells are defective for some types of repair
activity in UV-damaged DNA. In summary, the patient had a previously unknown disorder related to UV-induced
carcinogenesis, with defective DNA repair.
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INTRODUCTION
Exposure to UV radiation has several different effects on
human skin. Acute effects include erythema, tanning, and
immunosuppression, and long-term effects include photoaging
and carcinogenesis (Daya-Grosjean and Sarasin, 2005). During
the evolution of UV-induced carcinogenesis, a variety of
alterations and instability in genomic DNA occur through the
accumulation of DNA lesions. UV irradiation produces two
predominant types of DNA lesions: cyclobutane pyri-
midine dimers (CPD) and pyrimidine (6-4) pyrimidone
photoproducts (6-4PP) (Lippke et al., 1981; Mitchell and
Nairn, 1989). If not repaired through nucleotide excision repair
(NER), these UV-induced lesions lead to mutations during
replication, specifically C to T or tandem CC to TT transitions
(Afaq et al., 2005), and lead to variable instabilities, including
epigenetic alterations of oncogenic, tumor suppressive, and
cell-cycle control signaling pathways (Hussein, 2005).
The widely conserved NER process is an important repair
system, and is responsible for removing several kinds of DNA
lesions, particularly those induced by UV irradiation that
distort the DNA helix, CPD, and 6-4PP (Prakash and Prakash,
2000). Defects in NER result in rare autosomal-recessive
diseases, known as xeroderma pigmentosum (XP) and
Cockayne syndrome (CS). Hebra and Kaposi first described
XP in 1874. Defining characteristics include photosensitivity,
pigment changes, and neoplasia in the skin (Kraemer and
Slor, 1985; Kraemer et al., 1994). Some patients with XP also
have neurological complications. Seven XP complementation
groups (XP-A to -G) with defective NER are recognized
(Hanawalt, 2002), and a variant form (XP-V) with normal
NER, but defective translesion DNA synthesis, also occurs
(Masutani et al., 1999). CS is an inherited syndrome
characterized by short stature, mental deficiency, photosen-
sitivity, disproportionately large hands, feet, and ears, ocular
defects, and extensive demyeliation (Nance and Berry, 1992).
CS is distinguished from XP by these physical characteristics
and lack of cutaneous malignancies (Lehmann, 2003).
To diagnose cells derived from photosensitive patients in
our laboratory, a simple method has been established that
examines unscheduled DNA synthesis (UDS), recovery of
RNA synthesis (RRS), and recovery of replicative DNA
synthesis (RDS) (Itoh et al., 1996). XP-A through G cells
(except for XP-E) are characterized by reduced UDS, whereas
CS cells have normal UDS and reduced RRS. XP-V cells show
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normal UDS and RRS, but reduced RDS. XP-E cells show
normal USD, RRS, and RDS, but exhibit reduced UV-
damaged DNA-binding protein (DDB) activity (Feldberg
and Grossman, 1976; Kataoka and Fujiwara, 1991) (Table 2).
The host-cell reactivation (HCR) assay is a simple method to
diagnose the DNA repair capacity in cells (Qiao et al., 2002).
Moreover, this analysis of the DNA repair capacity can be
confirmed by a complementation assay, introducing UV-
damage endonuclease (UVDE) into the cells. UVDE intro-
duces a nick immediately 50 to CPD, 6-4PP, or abasic sites
(AP sites) and initiates an excision repair pathway (Freyer
et al., 1995; Yasui and McCready, 1998; Kanno et al., 1999).
In this study, we diagnosed a Japanese woman having
several skin tumors in sun-exposed areas who also exhibited
a new disorder with defective DNA repair. The patient
showed no clinical or cellular hypersensitivity to UV light,
and although cells established from this patient showed
impaired repair activity for UV-damaged DNA, the cells did
not appear to be like those from XP or CS patients in terms of
UDS, RRS, and RDS.
RESULTS AND DISCUSSION
Clinical state of the patient
KPSX7, a 67-year-old Japanese woman, gave a history of
freckling in sun-exposed areas, which had developed since
her teens. Otherwise, she had a typical sun exposure history
with an indoor occupation, and she had never suffered any
other symptoms of sunburn. There was no risk of exposure to
UV or other DNA-damaging agents in her job. She had
developed several verrucae and undiagnosed skin tumors
since her 20s, and many actinic keratoses, basal cell
carcinomas, and squamous cell carcinomas since her 50s in
sun-exposed areas. She had more than 50 tumors on her
hands, arms, and legs, but no tumors on her face (Figure 1).
A skin biopsy was taken from each developing tumor, and if
the histological findings revealed malignancy (Figure 2), the
entire lesion was subsequently excised and the defect was
closed with a skin graft. Her parents were not consangui-
neous. All her siblings had similar skin lesions. Physical
examinations, including neurological status, were negative
(Table 1). Results of blood chemistries, urinalysis including
urinary porphyrin, fecal porphyrin analyses, and minimal
erythema dose (99mJ/cm2) were normal.
Normal UV sensitivity of fibroblasts from the patient
We established primary fibroblasts from the patient and
named them KPSX7. The UV sensitivity of KPSX7 cells was
measured by a colony-forming assay in the presence or
absence of caffeine after UV irradiation compared with Turu
and Mori cells (normal primary fibroblasts). KPSX7 cells
showed similar survival to Turu cells when the cells were
irradiated with a low dose of UV (Figure 3a). The presence of
caffeine in the medium did not affect post-UV survival.
Moreover, KPSX7 showed similar sensitivity to Turu and Mori
cells when the cells were irradiated with a high dose of UV
(Figure 3b).
KPSX7 cells differ from XP and CS cells
As the clinical features of the patient resembled those of XP,
despite the absence of photosensitivity (Table 1), we
examined UDS and RRS in the KPSX7 cells and compared
them with normal and XP-A primary fibroblasts. Turu cells
showed numerous dots in their nuclei after UV irradiation
(Figure 4a). In contrast, KPSX3 (XP-A) cells displayed few
dots, indicating that normal fibroblasts have robust UDS
activity, whereas XP-A fibroblasts have impaired UDS
activity. KPSX7 cells showed a similar number of dots to
Turu cells, indicating that KPSX7 cells have normal UDS
activity. We then examined RRS in KPSX7 cells after UV
a b
Figure 1. Clinical manifestations of patient KPSX7. Photograph of the face
(a) and hands (b) of a 67-year-old Japanese woman.
Figure 2. Histological findings of the squamous cell carcinoma from
patient’s hand. The lesion showed proliferation of atypical squamous cells
with hyperkeratosis and dyskeratotic cells. (a) Bar¼ 1mm; (b) 500 mm.
Table 1. Clinical features of XP, CS, and the patient
Clinical features XP CS Patient
Skin
Acute sunburn + + 
Skin tumors +  +
Freckling +  +
Others
Neurological findings 71 + 
Cachectic dwarfism  + 
Pupillary abnormalities  + 
Osteoporosis  + 
CS, Cockayne syndrome; XP, xeroderma pigmentosum.
1XP complementation groups C, E, F, and V do not show neurological
findings.
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irradiation (Figure 4b). The number of dots in KPSX7 cells
decreased dramatically at 3 hours post-UV irradiation, and
had recovered at 24 hours post-irradiation, indicating that
KPSX7 cells have normal RRS activity. Since KPSX7 cells
showed normal UDS and RRS, we concluded that KPSX7
cells were different from both XP-A through G cells (except
for XP-E) and CS cells (Table 2).
Since reduced sensitivity after UV irradiation with caffeine
is a biological characteristic of XP-V cells (Broughton et al.,
2002), KPSX7 cells apparently differ from XP-V cells (Figure
3a). However, it is still possible that KPSX7 cells are XP-V
cells with unusual properties. XP-V cells show normal NER,
but are defective in translesion synthesis. We next measured
RDS and performed post-replication repair assay in KPSX7
cells to ascertain whether they were similar to XP-V cells. We
determined RDS by counting the number of S-phase cells in
cells irradiated with UV versus that in non-irradiated cells
(Figure 4c) (Itoh et al., 1996). The DNA synthesis rate after
UV dose (J/m2) UV dose (J/m2)
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Figure 3. UV survival of KPSX7 cells established from the patient.
Appropriate numbers of cells were inoculated into 100-mm dishes.
After UV irradiation at (a) 0–8 J/m2 (b) or 0–24 J/m2, cells were incubated
in the presence or absence of 1mM caffeine for 14 days, fixed, and stained
with Giemsa. Each point represents the average of three experiments
(mean7SD). Turu cells (J) and Mori cells ( ) were used as normal controls.
KPSX7 cells (&); Turu cells with 1mM caffeine (K); KPSX7 cells with 1mM
caffeine (’).
Turu KPSX7 KPSX3
UV (–) 3 hours 24 hours
KPS9
KPSX7
Turu
0 20 40 60 80 100
Rate of DNA synthesis (%)
Figure 4. Normal levels of UDS, RRS, and RDS in KPSX7 cells. (a) Normal UDS of KPSX7 cells. Turu (normal fibroblasts), KPSX7, or KPSX3 (XP-A) cells
were irradiated with UV at 30 J/m2, incubated for 1 hour with BrdU, and processed for immunostaining. Bar¼ 20mm (b) Normal RRS in KPSX7 cells. KPSX7 cells
were irradiated with UV at 30 J/m2 and incubated for 3 or 24 hours. The cells were microinjected with BrU into the cytoplasm, incubated for 0.5 hour, and
processed for immunostaining for BrU. Bar¼20 mm (c) Normal RDS in KPSX7 cells. The cells were irradiated with UV at 30 J/m2, incubated for 2 hours, labeled
with BrdU for 1 hour, and processed for immunostaining. RDS was calculated as the percentage of BrdU-positive cells with versus without UV irradiation. Each
point represents the average of three experiments (mean7SD).
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UV irradiation of KPSX7 cells was similar to that of Turu cells
(normal fibroblasts), whereas it was reduced to less than 5%
in KPS9 cells (XP-V cells). Moreover, in the post-replication
repair assay, KPSX7 cells had the same amount of size DNA
synthesized de novo after UV irradiation as non-irradiated
cells, as in Turu cells (Figure 5a and b). In contrast, KPS9 cells
synthesized less DNA de novo after UV irradiation than non-
irradiated cells (Figure 5c). Therefore, we concluded that
KPSX7 cells differ from XP-V cells.
KPSX7 cells are different from XP-E cells
As XP-E cells show normal UDS, RRS, and RDS but are
defective in DDB activity, we examined protein-binding
ability to UV-damaged DNA by gel mobility shift assays to
ascertain whether KPSX7 cells are similar to XP-E cells. Turu
cells showed robust protein-binding ability to UV-damaged
DNA, whereas OPS1 cells (XP-E) showed impaired protein-
binding ability (Figure 6a). KPSX7 cells showed similar
binding activity to that of Turu cells. These results indicate
that KPSX7 cells are different from XP-E cells. The XPC
protein is known to be polyubiquitinated in normal fibro-
blasts upon UV irradiation, although XPC is not ubiquitinated
in XP-E cells (Sugasawa et al., 2005). As shown in Figure 6b,
KPSX7 cells exhibited polyubiquitination of XPC upon UV
irradiation. These results also indicate that KPSX7 cells are
different from XP-E cells.
KPSX7 cells are defective in some DNA repair mechanism(s)
Although KPSX7 cells are different from XP and CS cells, it is
possible that the KPSX7 cells have defects in some type of
DNA repair because the patient exhibited considerable
actinic keratosis, basal cell carcinomas, and squamous cell
carcinomas in sun-exposed areas. It is widely accepted that
DNA repair plays an important role in preventing genetic
susceptibility to cancer. Thus, we tested DNA repair capacity
in KPSX7 cells by a HCR assay with UV-irradiated plasmids
containing a luciferase reporter gene. KPSX7 cells showed
similar luciferase activity to those of Turu and Mori cells
(NER-proficient fibroblasts) when plasmid DNA irradiated
with 250 J/m2 of UV was used. However, KPSX7 cells showed
lower luciferase activity than those of normal fibroblasts
Table 2. Biological Characteristics of XP, CS, and the
patient
Laboratory findings
XP (without
E and V) XP-E XP-V CS Patient
UV sensitivity +   + 
Enhancement of UV
Sensitivity by caffeine
  +  
Depress of UDS +    
Depress of RRS 71   + 
Depress of RDS ND  + ND 
Depress of DDB
activity
 +   
Depress of HCR + ND ND + +
CS, Cockayne syndrome; DDB, UV-damaged DNA-binding protein; HCR,
host-cell reactivation; ND, not determined; RDS, recovery of replicative
DNA synthesis; RRS, recovery of RNA synthesis; UDS, unscheduled DNA
synthesis; XP, xeroderma pigmentosum.
1XP complementation group C does not depress.
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Figure 5. Proficient postreplication repair of KPSX7 cells. Cells were
irradiated with UV at 5 J/m2, grown for 1 hour, and then pulse labeled with
[3H]thymidine. Centrifugation was performed for 90minutes at 50,000 r.p.m.
The top of gradient is to the right. &, unirradiated cells (control); ’,
UV-irradiated cells. (a) Turu cells; (b) KPSX7 cells; (c) KPS9 cells.
None Turu OPS1 KPSX7 Turu
UV damage
of probe
Unlabeled
competitor
Cell lysate
– – – –
––––––––
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Figure 6. Normal DDB activity in KPSX7 cells. (a) Normal protein-binding
ability to UV-irradiated DNA in KPSX7 cells. Whole-cell extract from Turu
(normal), KPSX7, or OPS1 (XP-E) cells was incubated with 32P-labeled
UV-irradiated DNA as a probe, in the presence or absence of unlabeled
competitor DNA (*non-irradiated and **UV-irradiated), and was then
processed for electrophoresis to separate the protein-bound DNA fraction.
The arrow indicates the protein-bound damaged DNA fraction. (b) Normal
post-translational modification of XPC protein in KPSX7 cells. Cells were
irradiated with UV at 10 J/m2 and incubated at 371C in the presence of 0.1mM
cycloheximide for the indicated times. Whole-cell extracts were prepared and
subjected to immunoblotting with an anti-XPC antibody. The arrow and
bracket indicate unmodified and polyubiquitinylated forms of XPC,
respectively. The asterisks indicate nonspecific crossreacting bands.
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when plasmid DNA irradiated with 750 J/m2 of UV was used
(Figure 7a). Since high UV dose induce some single- or
double-stranded DNA breaks and interstrand cross-links, we
examined HCR of KPSX7 cells when a plasmid containing
single- or double-stranded DNA breaks and interstrand cross-
links was used (Figures S1b–d). KPSX7 cells showed similar
luciferase activity to that in normal fibroblasts suggesting a
normal repair activity of strand breaks and interstrand cross-
links in KPSX7 cells. To confirm that KPSX7 cells are
defective in some type of DNA repair, we examined whether
the defective luciferase activity in the HCR assay could be
restored by introduction of UVDE into the cells. Indeed,
luciferase activity in KPSX7 cells was restored to the same
level as that in Turu cells (normal fibroblasts) by introducing a
plasmid expressing UVDE (Figure 7b). Because UVDE is
known to incise DNA containing CPD, 6-4PP, or AP sites
(Freyer et al., 1995; Yasui and McCready, 1998; Kanno et al.,
1999), we next examined whether KPSX7 cells exhibited
HCR when a plasmid containing AP sites was used. KPSX7
cells showed similar luciferase activity to that in normal
fibroblasts (Figure S1a), suggesting a normal repair activity of
AP sites in KPSX7 cells.
These results suggested that KPSX7 cells had a new form of
DNA repair defect, although a possibility still existed that
KPSX7 cells possessed a form similar to XP or CS, but with
unusual properties. To examine further this possibility, we
assessed whether expression of NER factors or polymerase Z
could restore the defective HCR activity in KPSX7 cells. The
expression of NER factors or polymerase Z did not correct the
defective HCR activity in KPSX7 cells (Figure 7c).
Efficient repair of 6-4PP and CPD in KPSX7 cells
To confirm that 6-4PP and CPD defects were efficiently
repaired in KPSX7 cells, we measured the amount of the
photoproducts by ELISA after UV irradiation. KPSX7 cells
showed a similar pattern of repairing 6-4PP and CPD to that
of MSU2 cells (normal fibroblasts) (Figure 8), indicating that
KPSX7 cells had normal efficiency in repairing the photo-
products.
In this study, we established KPSX7 cells from an elderly
Japanese woman who exhibited many freckles, actinic
keratosis, basal cell carcinomas, and squamous cell carcino-
mas. KPSX7 cells showed similar UDS, RDS, RRS, and DDB
activity to those of wild-type human fibroblasts, suggesting
that KPSX7 cells are different from those of XP and CS. KPSX7
cells showed only reduced HCR activity. It was reported that
the HCR repair capacity for UV-induced DNA damage is
reduced in elderly human cells (Takahashi et al., 2005) and
HCR activity seems to be decreased by in vitro as cultured
cells age (Moriwaki et al., 1996), although this is contro-
versial (Merkle et al., 2004). KPSX7 cells did show reduced
HCR activity when a high-dose UV-irradiated plasmid was
used in the assay, and we used KPSX7 cells at less than 17
passages and Turu cells (normal fibroblasts) at 16–24
passages. Moreover, the patient had exhibited skin lesions
since her 20s. Thus, we concluded that aging was not
responsible for the KPSX7 cells showing reduced HCR
activity.
We suggest two possibilities as to why KPSX7 cells
apparently have defective repair of high-dose UV-damaged
DNA; first, we suspect that some minor DNA lesions, other
than 6-4PP, CPD, or AP sites, were not repaired in KPSX7
cells and that these minor lesions may have induced skin
cancer in the patient. Data supporting the possibility are as
follows. The HCR activity recovered when UVDE was
expressed in the cells, and UVDE is known to repair DNA
containing 6-4PP, CPD, or AP sites (Freyer et al., 1995; Yasui
and McCready, 1998; Kanno et al., 1999). In KPSX7 cells,
however, 6-4PP and CPD were repaired with almost equal
efficiency to that seen in normal human fibroblasts, as
assessed by ELISA. Moreover, KPSX7 cells showed normal
HCR activity when a plasmid containing AP sites was used in
the assay. Thus, KPSX7 cells were apparently able to repair
6-4PP, CPD, and AP sites, suggesting that other lesions were
not repaired in these cells.
Alternatively, KPSX7 cells may be defective in a minor
subpathway of NER, which proceeds via at least two
alternative pathways. One is transcription-coupled DNA
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Figure 7. Defective HCR in KPSX7 cells. (a) KPSX7 (&) cells and normal
fibroblasts, Turu (J), and Mori ( ), were transfected with plasmids that were
irradiated with the indicated amounts of UV, and then incubated for 48 hours.
Lysate from the cells were subjected to an assay for the reporter gene product
(luciferase activity). Each point represents the average of three experiments
(mean7SD). (b) Restoration of HCR in KPSX7 cells by expression of UVDE.
Turu with mock plasmid (J), Turu with UVDE expression plasmid (K),
KPSX7 with mock plasmid (&), or KPSX7 with UVDE expression plasmid (’).
Cells were treated by the same method as (a) except that the cells were
co-transfected with the UVDE expression plasmid or the mock plasmid.
(c) Restoration of HCR in KPSX7 cells by introduction of NER factors
expression vector.
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repair, which removes lesions only in the actively transcribed
DNA strand, and another is global genome repair (GGR),
which removes lesions in any sequence of the genome
(Hanawalt, 2002). We suggest the existence of another
possible subpathway of NER, different from transcription-
coupled DNA repair or GGR, which normally repairs 6-4PP
or CPD in specific regions of the genome, but which is non-
functional in KPSX7 cells.
Although XP patients commonly have skin cancers, CS
patients, defective in transcription-coupled DNA repair, do
not (Lehmann, 2003). This difference between XP and CS
may be caused by faulty repair of particular types of
photoproducts in a specific region of the genome that
provokes chromosome instability (Parris and Kraemer,
1993; Bridges, 1998; Cleaver, 2005). The skin cancers of
sun-exposed areas are commonly induced by several condi-
tions other than XP. Nishigori et al. (1996) reported that
unrepaired UV-induced DNA damage in the skin activates
the production of cytokines that downregulate the immune
response. Halliday (2005) reviewed how UV causes
inflammation, gene mutation, and immunosuppression in
the skin through oxidative damage, and these processes
contribute to photocarcinogenesis. To ascertain whether
KPSX7 cells are defective for any other DNA damage repair
than NER, we investigated the sensitivities of KPSX7 cells to
X-rays, methyl methanesulfonate (MMS), mitomycin C
(MMC), or H2O2 (Figure S2). However, KPSX7 cells showed
normal sensitivity to these agents. We suggest that faulty
repair of a lesion in a specific region of the genome or
unknown lesions was a reasonable cause of the skin cancers
in our patient.
Finally, we recommend that the HCR assay be used to
evaluate the UV-damaged DNA repair capacity in patients
who have multiple skin cancers in sun-exposed areas, similar
to our patient, and that a group including patients with
defective HCR, but normal function in other DNA repair tests,
be collected. A new pathological model may then be
established by investigating the genetic backgrounds of these
patients. Further study of these cells may provide a clue to the
mechanism of UV-induced skin carcinogenesis.
MATERIALS AND METHODS
This study was approved by the Medical Ethics Committee of
the University of Kumamoto and was conducted according to the
Declaration of Helsinki Principles. Informed consent was obtained
from the patient.
Cells and culture conditions
We cultured primary human fibroblasts KPSX7 (established from
our patient), KPSX3 (XP-A), OPS1 (XP-E), KPS9 (XP-V), MSU2
(a generous gift from Dr Toshio Mori, Nara Medical University),
Mori, and Turu (wild-type, NER-proficient) in Dulbecco’s modified
Eagle’s minimum essential medium, supplemented with 10% fetal
bovine serum and antibiotics (penicillin and streptomycin) at 371C
and 5% CO2.
UV survival assay
Appropriate numbers of cells were seeded into 10-cm dishes. After
10 hours, cells were washed with phosphate-buffered saline (PBS)
and UV-irradiated at various doses. Cells were then incubated for 2
weeks. Colonies were fixed with 50% methanol, stained with 5%
Giemsa’s solution, and counted under a microscope.
UDS
Cells were seeded on coverslips and incubated until subconfluent.
Cells were washed with PBS, irradiated with UV at 30 J/m2, labeled
for 1 hour in medium containing 20 mM BrdU, and fixed with 70%
ethanol. The samples were denatured with 2M HCl and washed with
PBS. The cells were incubated with diluted anti-BrdU antibody
(PharMingen, San Diego, CA) in PBS for 1 hour at room temperature.
We then washed the cells in PBS and incubated them with the FITC-
conjugated anti-mouse secondary antibody. After washing the cells
on the coverslips, they were mounted on glass slides and examined
under a fluorescence microscope.
RRS
Cells on coverslips were washed with PBS, irradiated with UV at
30 J/m2, and incubated for various times. We then microinjected BrU
into the cytoplasm of the cells, incubated them for 0.5 hour, and
fixed the samples. The BrU incorporated into RNA was then detected
by the method described for UDS except for the denaturing step.
RDS
Cells on coverslips were treated with or without UV radiation at
30 J/m2, incubated for 2 hours, and labeled for 1 hour in medium
containing 20 mM BrdU. Samples were fixed and denatured. The
BrdU incorporated into DNA was detected by the method described
for UDS.
Post-replication repair assay
Semiconservative DNA replication after UV irradiation was mea-
sured by a method described elsewhere (Itoh et al., 1995). Briefly,
cells were irradiated with UV at 15 J/m2 and incubated for
60minutes before being labeled with [3H]thymidine (10 mCi/ml) for
30minutes. Cells were lysed with (0.2 M NaOH with 0.02M EDTA)
and X-ray-irradiated at 20Gy on ice. Cell suspensions were layered
onto 5–20% alkaline sucrose gradients with 0.1 M NaOH and
centrifuged at 50,000 r.p.m. for 90minutes at 41C in a P56ST rotor
(Hitachi, Tokyo, Japan). After centrifugation, drop fractions were
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Figure 8. Ability to repair CPD and 6-4PP in genomic DNA. KPSX7 (&) cells
or MSU2 ( ), were irradiated with 10 J/m2 UV and incubated for the
indicated periods. At each time point, genomic DNAs were purified from the
cells and used for quantitation of 6-4PP (a) or CPD (b) by ELISA. Each point
represents the average of three experiments (mean7SD).
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collected on Whatman Grade 17 paper strips, and the acid-insoluble
radioactivity was determined in a liquid scintillation counter.
Gel mobility shift assay
A gel shift assay was performed as described elsewhere (Chu and
Chang, 1988; Keeney et al., 1992; Itoh et al., 1999), with some
modifications. Briefly, 32P-labeled 66-base pair duplex DNA (0.2 ng)
irradiated with 6 kJ/m2 was incubated with whole-cell extracts (3mg)
for 15minutes at 301C. Samples were subjected to 5% polyacryla-
mide gel electrophoresis in Tris–borate/EDTA buffer. Dried gels were
analyzed using a Fujix Bio-Analyzer BAS-2000 (Fuji Photo Film,
Kanagawa, Japan).
Immunoblot
Whole-cell lysates were subjected to SDS-PAGE and transferred to a
polyvinylidene difluoride membrane (Millipore, Bedford, MA). After
blocking, the membrane was incubated with anti-XPC antibody
and followed by the ECL Western blotting detection system
(GE Healthcare, Buckinghamshire, UK).
Preparation of plasmids containing specific DNA lesions
The plasmid pRL-CMVluc (4,797 bp) containing the cytomegalovirus
immediate-early enhancer and promoter, along with a luciferase
gene, was used for the HCR assay. Treatment of the plasmid DNA
was as described elsewhere (Spivak and Hanawalt, 2006), with some
modifications. Briefly, to introduce photoproducts, plasmid in
Tris–EDTA buffer on ice was irradiated with UVC light (254 nm)
from a germicidal lamp for various times. To introduce AP sites,
plasmid DNA was mixed with 9 vol of sodium citrate buffer (10mM
sodium citrate, 100mM NaCl, adjusted to pH 4.0 with 10mM citric
acid) and incubated at 601C for various times. Samples were mixed
with an equal volume of 10 endonuclease III reaction buffer
(Trevigen, Gaithersburg, MD) and chilled on ice. Single-strand
breaks were generated by treatment of AP site-containing plasmid
with T4 endonuclease V for 60minutes at 371C. Double-strand
breaks were generated by treatment of plasmid with restriction
enzyme, Ehe1. To introduce interstrand cross-links, plasmid was
reacted with mitomycin C and sodium borohydride. The cross-
linking reaction was initiated by the addition of 1 vol% of 20mM
NaBH4 for 10minutes at 371C.
HCR assay
Cells were plated in 24-well dishes, incubated overnight, and
transfected with the plasmids indicated using Lipofectamine 2000
(Invitrogen, Carlsbad, CA). The cells were incubated at 371C for
48 hours, and then were lysed in reporter lysis buffer (Promega,
Madison, WI). Supernatant of the cell extract was mixed with
Luciferase Assay Substrate (Promega) at room temperature, and
luciferase activity was measured with a Mini Lumat LB9506 (Perkin-
Elmer, Wellesley, MA).
In vivo repair assay
Cells were irradiated with 10 J/m2 UVC light (254 nm) using a
germicidal lamp and incubated for various times. Genomic DNA
was purified with a DNeasy kit (Qiagen, Valencia, CA), and the
amount of CPD or 6-4PP in the DNA was determined by ELISA using
specific mAbs (TDM-2 or 64M-5, respectively), as described
previously (Mori et al., 1991; Wakasugi et al., 2002).
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SUPPLEMENTARY MATERIAL
Figure S1. Normal HCR in KPSX7 with variety damaged plasmid.
Figure S2. Normal sensitivity in KPSX7 cells to DNA-damaging agents.
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